Overview


According to FutureWise analysis the market for 3D cell culture in 2023 is US$ 1.65 billion, and is expected to reach US$ 3.87 billion by 2031 at a CAGR of 11.30%.

3D cell culture is a cutting-edge technique that involves cultivating cells in a three-dimensional environment to replicate the conditions found in living tissues more accurately. Unlike traditional two-dimensional (2D) cell culture systems, where cells are grown on flat surfaces like petri dishes, 3D cell culture aims to mimic the complex architecture and microenvironment of tissues and organs within the human body. In vivo, cells interact with neighbouring cells, the extracellular matrix, and other elements in their surroundings, influencing their behaviour and responses. By creating 3D cell culture models, researchers can study cellular behaviour in a more physiologically relevant context, offering a deeper understanding of how cells function and interact in their natural environment.

There are several techniques for 3D cell culture, including scaffold-based culture, where cells are seeded onto or within a three-dimensional scaffold made of materials like hydrogels, allowing for organized growth. Spheroid culture involves cells aggregating into multicellular structures called spheroids, which can be suspended in a liquid medium or embedded in a matrix. Organoids are another 3D culture model representing miniaturized organs derived from stem cells or tissue-specific progenitors. Bioreactors and microfluidic systems provide dynamic and controlled conditions, enabling the creation of more complex 3D culture models.

FutureWise Market Research has published a report that provides an insightful analysis of 3D Cell Culture Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that 3D Cell Culture Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • THERMO FISHER SCIENTIFIC
  • CORNING
  • LONZA GROUP
  • KURARAY CO
  • MERCK KGAA
  • INSPHERO
  • N3d Bioscience
  • Reprocell Incorporated
  • 3D Biotek
  • Mimetas BV

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the 3D Cell Culture Market

  • In August 2021, Amerigo Scientific introduced a new 3D Cell Culture system to its cell culture portfolio. This cutting-edge system boasts a range of research applications, including drug discovery, medicine, nanomaterials evaluation, and basic life science.

The 3D cell culture market is driven by a multitude of interconnected factors that have shaped its rapid growth and widespread adoption across various industries. One of the primary drivers is the rising frequency of chronic diseases and medical conditions, such as multiple organ failure, which has led to a soaring demand for organ transplants. However, the scarcity of organ donors has spurred the quest for alternative solutions, like regenerative medicine and tissue engineering, where 3D cell culture plays a pivotal role in cultivating organoids and functional tissue constructs for transplantation and drug analysis responses. The market has witnessed significant advancements in product offerings, with recent launches of innovative solutions that better mimic conditions in the human body. For instance, the introduction of FaCellitate's BIOFLOAT, a user-friendly and optimized 3D cell culture system, has further propelled the market's expansion by meeting the demand for more realistic and reliable models. Collaborative efforts between pharmaceutical companies, academic institutions, and research centers have also been influential in propelling the growth of 3D cell culture technology. These partnerships accelerate technological advancements, foster knowledge exchange, and promote the standardization of protocols, driving wider adoption of 3D cell culture techniques. Supportive government legislation and funding from public and private organizations have further spurred research and development activities in the market. Investments such as ZEISS Ventures' support for InSphero in March 2023 and the substantial series B funding of USD 23.1 million received by Inventia Life Science in December 2021 to launch their 3D cell culture platform in the U.S. market have paved the way for innovative breakthroughs and market expansion. However, the 3D cell culture market faces some challenges related to complexity, cost, standardization, and scaling-up. Addressing these hurdles will be crucial to realizing the full potential of 3D cell culture and its widespread adoption in various industries.

By Product

  • Scaffold-based 3D Cell Cultures
    • Hydrogels/ECM Analogs
    • Solid Scaffolds
    • Micropatterned Surfaces
  • Scaffold-free 3D Cell Cultures
    • Low Attachment Plates
    • Hanging Drop Plates
    • 3D Bioreactors
    • 3D Petri Dishes
  • Microfluidics-based 3D Cell Cultures
  • Magnetic and Bioprinted 3D Cell Cultures

By Application

  • Cancer and Stem Cell Research
  • Drug Discovery and Toxicology Testing
  • Tissue Engineering and Regenerative Medicine

By End User

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Cosmetics Industry
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America emerged as the dominant market share holder in the field of 3D cell culture in 2022. Several factors contributed to this dominance, including the region's advanced healthcare infrastructure, developed economies, and the presence of key players in the industry. These established companies drive the market's growth through various strategic initiatives. Moreover, North America's 3D cell culture market benefited from a supportive regulatory framework, which facilitated research and development activities in this field. The regional governments also showed significant support for the advancement of three-dimensional culture models, providing additional impetus to the market's expansion.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the market By Product, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   3D Cell Culture Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   3D Cell Culture Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of 3D Cell Culture Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   3D Cell Culture Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   3D Cell Culture Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Scaffold-based 3D Cell Cultures
         1.1 . Hydrogels/ECM Analogs
         1.2 . Solid Scaffolds
         1.3 . Micropatterned Surfaces
        2. Scaffold-free 3D Cell Cultures
         2.1 . Low Attachment Plates
         2.2 . Hanging Drop Plates
         2.3 . 3D Bioreactors
         2.4 . 3D Petri Dishes
        3. Microfluidics-based 3D Cell Cultures
        4. Magnetic and Bioprinted 3D Cell Cultures

  • 8.   3D Cell Culture Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cancer and Stem Cell Research
        2. Drug Discovery and Toxicology Testing
        3. Tissue Engineering and Regenerative Medicine

  • 9.   3D Cell Culture Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical and Biotechnology Companies
        2. Research Institutes
        3. Cosmetics Industry
        4. Other End Users

  • 10.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Taiwan
         2.9. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. THERMO FISHER SCIENTIFIC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. CORNING
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. LONZA GROUP
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. KURARAY CO
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5 . MERCK KGAA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6 . INSPHERO
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. N3d Bioscience
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Reprocell Incorporated
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. 3D Biotek
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Mimetas BV
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients